These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease. Knecht H; Berger C; McQuain C; Rothenberger S; Bachmann E; Martin J; Esslinger C; Drexler HG; Cai YC; Quesenberry PJ; Odermatt BF Oncogene; 1999 Nov; 18(50):7161-7. PubMed ID: 10597317 [TBL] [Abstract][Full Text] [Related]
24. Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion. Xiao W; Chen WW; Sorbara L; Davies-Hill T; Pittaluga S; Raffeld M; Jaffe ES Hum Pathol; 2016 Sep; 55():108-116. PubMed ID: 27184478 [TBL] [Abstract][Full Text] [Related]
25. Pediatric Hodgkin lymphoma in a South Indian regional cancer center: its immunomorphology, tumor-associated macrophages, and association with Epstein-Barr virus. Zameer MA; Premalata CS; Arunakumari B; Appaji L; Rao CR Pediatr Hematol Oncol; 2015 May; 32(4):229-38. PubMed ID: 25252151 [TBL] [Abstract][Full Text] [Related]
26. LMP1 and Dynamic Progressive Telomere Dysfunction: A Major Culprit in EBV-Associated Hodgkin's Lymphoma. Knecht H; Mai S Viruses; 2017 Jun; 9(7):. PubMed ID: 28654015 [TBL] [Abstract][Full Text] [Related]
27. Aberrant expression of cyclin a correlates with morphogenesis of reed-sternberg cells in Hodgkin lymphoma. Chang KC; Chang Y; Jones D; Su IJ Am J Clin Pathol; 2009 Jul; 132(1):50-9. PubMed ID: 19864233 [TBL] [Abstract][Full Text] [Related]
28. Co-expression of Epstein-Barr virus latent membrane protein and vimentin in "aggressive" histological subtypes of Hodgkin's disease. Carbone A; Gloghini A; Zanette I; Canal B; Rizzo A; Volpe R Virchows Arch A Pathol Anat Histopathol; 1993; 422(1):39-45. PubMed ID: 7679848 [TBL] [Abstract][Full Text] [Related]
29. [Internal deletions of the latent membrane protein oncogenes of Epstein-Barr virus in Hodgkin's disease are almost identical with those of Asiatic nasopharyngeal carcinoma]. Odermatt BF; Heitz PU; Bachmann E; Brousset P; Sandvej K; Knecht H Verh Dtsch Ges Pathol; 1994; 78():324-8. PubMed ID: 7534006 [TBL] [Abstract][Full Text] [Related]
30. High prevalence of a 30-base pair deletion in the Epstein-Barr virus (EBV) latent membrane protein 1 gene and of strain type B EBV in Mexican classical Hodgkin's disease and reactive lymphoid tissue. Dirnhofer S; Angeles-Angeles A; Ortiz-Hidalgo C; Reyes E; Gredler E; Krugmann J; Fend F; Quintanilla-Martinez L Hum Pathol; 1999 Jul; 30(7):781-7. PubMed ID: 10414496 [TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus-induced B-cell proliferation of Hodgkin's and Reed-Sternberg cell pheno- and genotype may develop in peripheral T-cell lymphomas. Pajor L; Kajtár B; Jáksó P; Lacza A; László R; Radványi G; Mórocz I; Tóth A; Varga G Histopathology; 2006 Nov; 49(5):553-7. PubMed ID: 17064310 [No Abstract] [Full Text] [Related]
32. Latent membrane protein 1 deletion mutants accumulate in reed-sternberg cells of human immunodeficiency virus-related Hodgkin's lymphoma. Guidoboni M; Ponzoni M; Caggiari L; Lettini AA; Vago L; De Re V; Gloghini A; Zancai P; Carbone A; Boiocchi M; Dolcetti R J Virol; 2005 Feb; 79(4):2643-9. PubMed ID: 15681466 [TBL] [Abstract][Full Text] [Related]
33. Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma. Gulley ML; Glaser SL; Craig FE; Borowitz M; Mann RB; Shema SJ; Ambinder RF Am J Clin Pathol; 2002 Feb; 117(2):259-67. PubMed ID: 11863222 [TBL] [Abstract][Full Text] [Related]
34. Demonstration by single-cell PCR that Reed--Sternberg cells and bystander B lymphocytes are infected by different Epstein--Barr virus strains in Hodgkin's disease. Faumont N; Al Saati T; Brousset P; Offer C; Delsol G; Meggetto F J Gen Virol; 2001 May; 82(Pt 5):1169-1174. PubMed ID: 11297691 [TBL] [Abstract][Full Text] [Related]
35. Composite lymphoma of nodular lymphocyte-predominant and classical Hodgkin lymphoma-Epstein-Barr virus association suggests divergent pathogenesis despite clonal relatedness. Szczepanowski M; Masqué-Soler N; Oschlies I; Schmidt W; Lück A; Klapper W Hum Pathol; 2013 Jul; 44(7):1434-9. PubMed ID: 23427872 [TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus latent membrane protein-1 upregulates autophagy and promotes viability in Hodgkin lymphoma: Implications for targeted therapy. Lin HC; Chang Y; Chen RY; Hung LY; Chen PC; Chen YP; Medeiros LJ; Chiang PM; Chang KC Cancer Sci; 2021 Apr; 112(4):1589-1602. PubMed ID: 33525055 [TBL] [Abstract][Full Text] [Related]
37. Contribution of the Epstein-Barr Virus to the Pathogenesis of Hodgkin Lymphoma. Murray P; Bell A Curr Top Microbiol Immunol; 2015; 390(Pt 1):287-313. PubMed ID: 26424651 [TBL] [Abstract][Full Text] [Related]
38. Tumor microenvironment and RIG-I signaling molecules in Epstein Barr virus-positive and -negative classical Hodgkin lymphoma of the elderly. Satoh T; Wada R; Yajima N; Imaizumi T; Yagihashi S J Clin Exp Hematop; 2014; 54(1):75-84. PubMed ID: 24942949 [TBL] [Abstract][Full Text] [Related]
39. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina. Chabay P; De Matteo E; Merediz A; Preciado MV Arch Virol; 2004 Aug; 149(8):1515-26. PubMed ID: 15290377 [TBL] [Abstract][Full Text] [Related]
40. Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome. Herling M; Rassidakis GZ; Medeiros LJ; Vassilakopoulos TP; Kliche KO; Nadali G; Viviani S; Bonfante V; Giardini R; Chilosi M; Kittas C; Gianni AM; Bonadonna G; Pizzolo G; Pangalis GA; Cabanillas F; Sarris AH Clin Cancer Res; 2003 Jun; 9(6):2114-20. PubMed ID: 12796376 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]